Hemostatic Instruments Market (By Type: Active, Mechanical, Flowable; By Application: Cardiovascular Surgery, General Surgery, Orthopedic Surgery)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

The global hemostatic instruments market is growing immensely owing to several growth factors such as the rising number of surgical procedures, surging cases of sports-related injuries, and increasing incidence of chronic diseases such as cardiovascular, orthopedic, and trauma across the globe. The increase in number of surgical procedures may lead to several complications including bleeding, which is anticipated to surge the demand for hemostatic instruments in the forecast period. Additionally, increasing access to health care services, technological advancements, and the entry of new manufacturers are other factors expected to augment the hemostatic devices market.

Hemostasis and tissue sealing agents are used to prevent hemorrhage. During surgery, it is very essential to stop the excessive bleeding in patient to avoid further organ damage or death by excess blood loss. This has created the need for hemostasis instruments in the forecast period. The hemostatic instruments market is segmented on the basis of type and application. On the basis of type, the market is segmented into mechanical, flowable, and active. Mechanical type is anticipated to hold highest market share in 2021. Based on application, the market is segmented into cardiovascular surgery, general surgery, orthopedic surgery, gynecologic surgery and others.

The North America is expected to dominate the market in 2021 owing to advanced treatment facilities and increasing focus on effective blood management among patients during surgeries is expected to foster regional growth.

Some of the major companies operating in the market are Johnson & Johnson, Medtronic, CryoLife, Inc., Becton, Dickinson and Company, Pfizer, Baxter, Stryker, CryoLife, Inc., B. Braun Melsungen AG, and Smith & Nephew. These market players are focusing on several market strategies such as product launches, mergers & acquisitions, partnerships, collaboration, and others to strengthen their market position. For instance, in May 2022, BD announced the launch of scientific office in Egypt to enhance patient safety and healthcare worker safety in the Middle East & North America (MENA) region.

Market Segmentation

  • By Type
    • Active
    • Mechanical 
    • Flowable
  • By Application
    • Cardiovascular Surgery
    • General Surgery
    • Orthopedic Surgery
    • Gynecologic Surgery 
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hemostatic Instruments Market 

5.1. COVID-19 Landscape: Hemostatic Instruments Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hemostatic Instruments Market, By Type

8.1. Hemostatic Instruments Market, by Type, 2022-2030

8.1.1. Active

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Mechanical

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Flowable

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Hemostatic Instruments Market, By Application

9.1. Hemostatic Instruments Market, by Application, 2022-2030

9.1.1. Cardiovascular Surgery

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. General Surgery

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Orthopedic Surgery

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Gynecologic Surgery

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Hemostatic Instruments Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type (2017-2030)

10.1.2. Market Revenue and Forecast, by Application (2017-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Type (2017-2030)

10.1.3.2. Market Revenue and Forecast, by Application (2017-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type (2017-2030)

10.2.2. Market Revenue and Forecast, by Application (2017-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Type (2017-2030)

10.2.3.2. Market Revenue and Forecast, by Application (2017-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type (2017-2030)

10.3.2. Market Revenue and Forecast, by Application (2017-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Type (2017-2030)

10.3.3.2. Market Revenue and Forecast, by Application (2017-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type (2017-2030)

10.4.2. Market Revenue and Forecast, by Application (2017-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Type (2017-2030)

10.4.3.2. Market Revenue and Forecast, by Application (2017-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type (2017-2030)

10.5.2. Market Revenue and Forecast, by Application (2017-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Type (2017-2030)

10.5.3.2. Market Revenue and Forecast, by Application (2017-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

Chapter 11. Company Profiles

11.1. Johnson & Johnson

11.1.1. Company Overview

11.1.2. Type Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Medtronic

11.2.1. Company Overview

11.2.2. Type Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. CryoLife, Inc.

11.3.1. Company Overview

11.3.2. Type Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Becton

11.4.1. Company Overview

11.4.2. Type Offerings

11.4.3. Financial Performance

11.4.4. LTE Scientific

11.5. Dickinson and Company

11.5.1. Company Overview

11.5.2. Type Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Pfizer

11.6.1. Company Overview

11.6.2. Type Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Baxter

11.7.1. Company Overview

11.7.2. Type Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Stryker

11.8.1. Company Overview

11.8.2. Type Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. CryoLife, Inc.

11.9.1. Company Overview

11.9.2. Type Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. B. Braun Melsungen AG

11.10.1. Company Overview

11.10.2. Type Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers